Multiple active receptor conformation, agonist efficacy and maximum effect of the system: The conformation-based operational model of agonism

Drug Discovery Today

Volumn 18, Issue 7-8, 2013, Pages 365-371

  Roche, David ^a   Gil, Debora ^a   Giraldo, Jesús ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR;

AGONIST; CONFORMATION; MODEL; REVIEW;

MODELS, BIOLOGICAL; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE;

EID: 84875729319     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.12.004     Document Type: Review

References (41)

1. T. Kenakin, and A. Christopoulos Analytical pharmacology: the impact of numbers on pharmacology Trends Pharmacol. Sci. 32 2011 189 196
2. J.W. Black, and P. Leff Operational models of pharmacological agonism Proc. R. Soc. Lond. B: Biol. Sci. 220 1983 141 162 (Pubitemid 14217337)
3. D. Mackay Concentration-response curves and receptor classification: null method or operational model? Trends Pharmacol. Sci. 9 1988 202 205
4. P. Leff Estimation of agonist affinity and efficacy by direct, operational model-fitting J. Pharmacol. Methods 23 1990 225 237 (Pubitemid 20134917)
5. P. Leff Analysis of agonist action using the operational model Trends Pharmacol. Sci. 9 1988 395 398 (Pubitemid 18265589)
6. J.W. Black An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation Br. J. Pharmacol. 84 1985 561 571 (Pubitemid 15169246)
7. J. Giraldo The slope parameter and the receptor reserve Trends Pharmacol. Sci. 19 1998 445 446
8. J. Giraldo Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models Pharmacol. Ther. 95 2002 21 45
9. J. Giraldo On the fitting of binding data when receptor dimerization is suspected Br. J. Pharmacol. 155 2008 17 23
10. 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists Proc. Natl. Acad. Sci. U. S. A. 99 2002 12471 12476
11. M. Engstrom Superagonism at the human somatostatin receptor subtype 4 J. Pharmacol. Exp. Ther. 312 2005 332 338 (Pubitemid 40096486)
12. R. Mistry An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins Br. J. Pharmacol. 144 2005 566 575 (Pubitemid 40349464)
13. S. Engel Low affinity analogs of thyrotropin-releasing hormone are super-agonists J. Biol. Chem. 281 2006 13103 13109 (Pubitemid 43855220)
14. o1 by the Ghrelin receptor Mol. Pharmacol. 76 2009 802 811
15. S. Niemczyk A super-agonist of growth hormone-releasing hormone causes rapid improvement of nutritional status in patients with chronic kidney disease Kidney Int. 77 2010 450 458
16. R. Schrage Agonists with supraphysiological efficacy at the muscarinic M(2) acetylcholine receptor Br. J. Pharmacol. 2012 10.1111/bph.12003 [Epub ahead of print]
17. N.J. Smith When simple agonism is not enough: emerging modalities of GPCR ligands Mol. Cell. Endocrinol. 331 2011 241 247
18. P. Leff Can operational models of agonism provide a framework for classifying hormone receptors? J.W. Black, Perspectives on Receptor Classification 1987 Alan R. Liss, Inc. New York 157 167
19. T. Kenakin A simple method for quantifying functional selectivity and agonist bias ACS Chem. Neurosci. 3 2012 193 203
20. R.F. Furchgott The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes N.J. Harper, A.B. Simmonds, Advances in Drug Research 3rd edn 1966 Academic Press 21 55
21. B.K. Kobilka, and X. Deupi Conformational complexity of G-protein-coupled receptors Trends Pharmacol. Sci. 28 2007 397 406 (Pubitemid 47087966)
22. 2 adrenergic receptor J. Biol. Chem. 276 2001 24433 24436
23. 2 adrenergic receptor: observation of conformational substates in a membrane protein Proc. Natl. Acad. Sci. U. S. A. 98 2001 8469 8474 (Pubitemid 32678051)
24. 2 adrenoceptor. Kinetic evidence for intermediate conformational states J. Biol. Chem. 279 2004 686 691 (Pubitemid 38044873)
25. 2-adrenoceptor Nat. Chem. Biol. 2 2006 417 422 (Pubitemid 44114919)
26. 2-adrenoceptor: insights from fluorescence resonance energy transfer studies J. Biol. Chem. 282 2007 13895 13905 (Pubitemid 47100565)
27. X.J. Yao The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex Proc. Natl. Acad. Sci. U. S. A. 106 2009 9501 9506
28. A.W. Kahsai Multiple ligand-specific conformations of the beta2-adrenergic receptor Nat. Chem. Biol. 7 2011 692 700
29. 2 adrenergic receptor revealed by HDX Structure 19 2011 1424 1432
30. J.L. Baneres Molecular characterization of a purified 5-HT4 receptor: a structural basis for drug efficacy J. Biol. Chem. 280 2005 20253 20260
31. S. Mary Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor Proc. Natl. Acad. Sci. U. S. A. 109 2012 8304 8309
32. 2 adrenergic receptor Structure 20 2012 1391 1402
33. S. Rajagopal Teaching old receptors new tricks: biasing seven-transmembrane receptors Nat. Rev. Drug Discov. 9 2010 373 386
34. S. Rajagopal Quantifying ligand bias at seven-transmembrane receptors Mol. Pharmacol. 80 2011 367 377
35. K.A. Jacobson, and S. Costanzi New insights for drug design from the X-ray crystallographic structures of GPCRs Mol. Pharmacol. 82 2012 361 371
36. T. Kenakin Efficacy in drug receptor theory: outdated concept or under-valued tool? Trends Pharmacol. Sci. 20 1999 400 405 (Pubitemid 29450360)
37. P.G. Strange Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors Br. J. Pharmacol. 153 2008 1353 1363 (Pubitemid 351492449)
38. J. Giraldo How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue Drug Discov. Today 15 2010 411 415
39. D. Colquhoun Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors Br. J. Pharmacol. 125 1998 923 947 (Pubitemid 28495353)
40. D.H. Jenkinson Finding affinity constants for agonists by the irreversible antagonists method Trends Pharmacol. Sci. 10 1989 16 17
41. T. Kenakin Efficacy at G-protein-coupled receptors Nat. Rev. Drug Discov. 1 2002 103 110 (Pubitemid 41646517)